Document is current
Any future updates will be listed below
-
Authors
Bernard, Edmond-Jean
Fedorak, Richard N.
Jairath, Vipul
-
Funding
Funding for this research was provided by:
Janssen Canada
- License Information
-
More Information
Article History
Received: 9 April 2019
Accepted: 28 December 2019
First Online: 22 January 2020
Compliance with Ethical Standards
:
: Edmond-Jean Bernard has served as a speaker and consultant for Janssen, Abbvie, Takeda, Shire, Ferring, Allergan, Pfizer, and Merck. Richard N. Fedorak has served as a speaker and consultant for AbbVie Canada, Inc. and Janssen Canada, Inc. Vipul Jairath has received consulting fees from AbbVie, Eli Lilly, GlaxoSmithKline, Arena pharmaceuticals, Genetech, Pendopharm, Sandoz, Merck, Takeda, Janssen, Robarts Clinical Trials, Topivert, and Celltrion, and speaker’s fees from Takeda, Janssen, Shire, Ferring, Abbvie, and Pfizer.
